TPU is constantly seeking to acquire products/technologies that complement the company's pipeline. And for companies looking for a product-life-cycle extension or a new drug delivery system, Teikoku Pharma is the strategic partner of choice. More
Hemosol BioPharma Inc. is seeking to license and/or acquire registered or late stage protein therapeutic products such as: plasma proteins, recombinant proteins, enzymes, monoclonal antibodies, sterile injectables More
APR is interested to in-license new early stage, innovative and patent protected products/technologies (preferably off patent or close to expiry) for oral, topical or transdermal administration More